- #Microsoft accounting software pharmaceutical how to#
- #Microsoft accounting software pharmaceutical verification#
The date these items were purchased and supplier they came from are also tracked, allowing you to monitor an individual group of products (or shipment) from the supplier to your own warehouse and ultimately to the customer. Lot tracking, or batch tracking, allows for product traceability to keep track of which customers received specific groups (or shipments) of items and when they were received.
#Microsoft accounting software pharmaceutical how to#
Blog: Part 6 – How to Manage DSCSA Requirements with Pharmaceutical Software.Blog: Part 5 – Drug Supply Chain Security Act (DSCSA) – Annual Reporting.Blog: Part 4 – Serialized Numerical Identifier (SNI) and the Drug Supply Chain Security Act.Blog: Part 3 – DSCSA: Suspect and Illegitimate Product Handling and Notification.Blog: Part 2 – Drug Supply Chain Security Act (DSCSA) Transaction Report (T3).Blog: Part 1 – Drug Supply Chain Security Act (DSCSA) and Pharmaceutical Distribution.Learn more about the Drug Supply Chain Security Act (DSCSA) and Pharmaceutical
#Microsoft accounting software pharmaceutical verification#
The goal of this transition is to permit the verification of the legitimacy of the drug products, facilitate more efficient and timely recall procedures and protocols, and enhance the detection and notification of illegal products.įor wholesale distributors dealing with pharmaceuticals, Blue Link closely monitors FDA, DEA and the progression of DSCSA requirements and frequently consults with existing customers and industry experts to ensure the pharmaceutical specific functionality offered continues to meet the needs of the industry and new standards/regulations as they come into effect. Upon the completion of the ten-year implementation process, the resulting system in place will enable the communication of information at the individual package level identifying where a specific drug has been at different stages of the supply chain. The DSCSA outlines several phases aimed at establishing an interconnected platform that will successfully identify and trace specific prescription drugs as they move through the supply chain. The Drug Supply Chain Security Act (DSCSA), signed into legislation by US President Barack Obama on November 27, 2013, ushered in a new age of transparency and accountability in the pharmaceutical industry.